Unicoat Pharma ApS: Financial statements 2018
CVR: 37166707
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 449,242 and a net result of DKK 362,088 compared with DKK 343,853 the year before. That is an increase of 4.2% compared with the year before. Equity in the 2018 report amounted to DKK 489,789. The solvency ratio was 36.6%.
- Gross Profit
- DKK 449,242
- Profit/Loss
- DKK 362,088
- Equity
- DKK 489,789
- Total Assets
- DKK 1,338,960
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 449 t. | 362 t. | 490 t. | - |
| 2017 | - | 431 t. | 344 t. | 428 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Unicoat Pharma ApS has published its annual report for 2017. Gross profit came to DKK 431,044, and the net result was DKK 343,853.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.